Dose responses of vitamin D3 supplementation on arterial stiffness in overweight African Americans with vitamin D deficiency: A placebo controlled randomized trial

PLoS ONE
Q1
Dec 2017
Citations:52
Influential Citations:1
Interventional (Human) Studies
82
S2 IconPDF Icon

Enhanced Details

Methods
70 overweight/obese African Americans aged 13–45 with suboptimal vitamin D status (serum 25(OH)D ≤ 20 ng/mL); randomized, double-blind, placebo-controlled trial.
Intervention
Vitamin D3, monthly oral capsules for 16 weeks at 18,000 IU/month (≈600 IU/day), 60,000 IU/month (≈2,000 IU/day), or 120,000 IU/month (≈4,000 IU/day); placebo capsules also given.
Results
Vitamin D3 supplementation increased serum 25(OH)D in a dose-dependent manner and reduced arterial stiffness measured by PWV in a dose-dependent fashion. Carotid-femoral PWV changes over 16 weeks were 0.13 m/s (placebo), 0.02 m/s (600 IU/day), −0.11 m/s (2,000 IU/day), and −0.70 m/s (4,000 IU/day). Carotid-radial PWV changes were 0.24 m/s (placebo), 0.09 m/s (600 IU/day), −0.57 m/s (2,000 IU/day), and −0.61 m/s (4,000 IU/day). The group-by-time dose-response was significant for both PWV measures (P<0.01 for carotid-femoral; P=0.03 for carotid-radial). The 4,000 IU/day dose yielded greater PWV reductions than 2,000 IU/day (carotid-femoral: −10.4% vs −2.0%; carotid-radial: −8.0% vs −7.4%). Blood pressure did not change significantly. Authors conclude that arterial stiffness improves in a dose‑response manner with vitamin D3 in this population; higher serum 25(OH)D (~35 ng/mL) may be needed for benefits to emerge and larger trials are needed to assess cardiovascular event risk.
Limitations
Small sample size; short duration (16 weeks); single-population study (overweight/obese African Americans with vitamin D deficiency); results may not generalize; female predominance; seasonal recruitment could affect vitamin D status.

Abstract

Background Clinical trials are scant and equivocal on whether vitamin D can ameliorate arterial stiffness, particularly in populations at high risk for vitamin D deficiency and cardiovascular disease (CVD). This study determined the dose-response eff...